DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Julie Fraser, Intern, Modbury Hospital, Adelaide, Australia; Chief Editor: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand, October 2015.
The Tzanck smear test is a simple and cheap test that relies on viewing and interpretation of single cells (cytology).
Arnault Tzanck described the technique in 1947 to distinguish various blistering conditions.
The test is not often performed, due to the development of histology, virological culture, polymerase chain reaction (PCR) and electron microscopy.1
The Tzanck smear is mainly used in an acute setting to rapidly detect a herpes infection or to distinguish Stevens- Johnson syndrome / toxic epidermal necrolysis (SJS/TEN) from staphylococcal scalded skin syndrome. However, it can be used to diagnose a variety cutaneous infections and blistering diseases.
Select a fresh blister on the patient.
The slide is stained. The choice of stain depends on the sample and diagnostic possibilities.
Giemsa stain is poured over the slide. After 15 minutes, the slide is washed with sterile water.
Toluidine blue is more rapid, as it only requires staining for 60 seconds.2
Characteristic cytological findings of Tzanck smears follow.3
The Tzanck smear test was found to have similar diagnostic accuracy to dermatoscopy in pigmented skin lesions.4
Initial results from a Tzanck smear should normally be confirmed by other techniques, such as biopsy or PCR.
Tzanck smear has the following benefits:
Tzanck smear requires expertise:
False negatives may occur in early or late disease.
See the DermNet NZ bookstore
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.